Clinical Trial Update: Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase I/II study evaluating the combination of RAD001 (everolimus) and Nexavar (sorafenib) in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)
• Nexavar (Sorafenib)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Carcinoma, Renal Cell | Phase 1, Phase 2 | Status: COMPLETED